Search

everythinglearnresearchcommunity

for

Search:↓

Androgen increases VEGF expression but not VEGFR-2 in rat corpus cavernous.

Finasteride is not effective for older women with hair loss.

Protease Nexin-1 is found in human hair growth cells and is affected by male hormones.

Different animals have unique versions of the enzyme that changes testosterone into another hormone, which is important for creating effective treatments for prostate and hair loss conditions.

Steroid sex hormones activate matriptase in prostate cancer cells but not in breast cancer cells.

5-alpha reductase deficiency leads to male sexual development issues and treatments like finasteride help with prostate enlargement and hair loss.

Suppressing certain hormones might help prevent prostate cancer.

Using testosterone-stimulated weanling rats can effectively replace castrated rats for anti-androgen testing, reducing animal stress.

The substance MK386 effectively blocked testosterone conversion and reduced cell growth in certain skin cells, but inhibiting 5α-reductase alone may not greatly improve acne.

Avicequinone C, a compound found in the Avicennia marina plant, can reduce hair loss by inhibiting a hormone linked to androgenic alopecia.

Women with AGA have more androstenedione and dihydrotestosterone, less copper and zinc; copper imbalance affects AGA; treatment improves hormones and minerals.

Reduced androgens linked to kinky hair disorder and hair loss; 5a-reductase inhibitors may help.

Many potential alopecia treatments need more testing to confirm they promote acceptable hair growth with minimal side effects.

Excessive pre-ejaculation can be treated with certain medications.

Italian guidelines recommend using trichoscopy for diagnosis and treatments like minoxidil for hair loss.

Men with thinner hair from genetic hair loss may be more likely to have an enlarged prostate.

Finasteride, dutasteride, and oral minoxidil are effective for treating hair loss, with spironolactone as an option for women.

Targeting multiple pathways may improve treatments for androgenetic alopecia.

Androgenic alopecia can be treated with minoxidil, finasteride, and hormonal therapy.

Finasteride's negative effects on brain tissue in male rats may be reversible after stopping the drug.

Hormones like androgens, estrogen, thyroid hormones, and stress hormones can contribute to hair loss, and treatments target these hormonal imbalances.

New liposome treatment successfully delivers CRISPR to deactivate a key enzyme in androgen-related disorders.

Finasteride and Dutasteride can improve hair growth in male baldness but may cause temporary sexual dysfunction and possibly affect fertility.

Finasteride and dutasteride are effective for male hair loss and enlarged prostate but may cause reversible sexual side effects.

Male pattern baldness may be linked to prostate cancer risk.

Dutasteride is approved to help manage prostate enlargement.

In 2005, men used finasteride mainly to treat an enlarged prostate.

Man experienced post-finasteride syndrome symptoms after using finasteride and dutasteride for hair loss.

Androgenetic alopecia, or hair loss, is caused by genetic factors and hormones, with different mechanisms in men and women, and can be linked to insulin resistance and polycystic ovary syndrome.

Both dutasteride and finasteride improve urinary symptoms, but dutasteride may be better at reducing the risk of prostate surgery and sudden inability to urinate.